WA People
BILL · 2021–22 SESSION · LATEST VERSION SSB 5020

SB 5020: Rx drug price increases

Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents.

Summary

  • Requires the Health Care Authority to identify prescription drugs with price increases not supported by clinical evidence and requires the Department of Revenue to assess a penalty against a drug manufacturer on revenue generated from the price increase.
  • Prohibits manufacturers from withdrawing a drug from the market to avoid paying the penalty.

From the Senate Bill Report (SB 5020), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 11, 2021
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Karen Keiser (D-33)
Introduced
January 11, 2021 in the Senate
Last action
January 10, 2022
Budget
Has a fiscal note
Versions
SB 5020, SSB 5020

AN ACT Relating to assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents;

Sponsors

Prime sponsor: Karen Keiser (D-33)

10 co-sponsors (10 Democrats, 0 Republicans)

June Robinson D-38Steve Conway D-29Senator D-47Bob Hasegawa D-11Patty Kuderer D-48Liz Lovelett D-40Christine Rolfes D-23Derek Stanford D-1Kevin Van De Wege D-24Claire Wilson D-30

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status. (SSB 5020)
  2. By resolution, reintroduced and retained in present status.
  3. Referred to Ways & Means. (SSB 5020)
  4. Referred to Ways & Means.
  5. HLTC - Majority; 1st substitute bill be substituted, do pass. (SSB 5020)
  6. Minority; do not pass. (SSB 5020)
  7. Minority; without recommendation. (SSB 5020)
  8. And refer to Ways & Means. (SSB 5020)
  9. And refer to Ways & Means.
  10. Minority; without recommendation.
  11. Minority; do not pass.
  12. HLTC - Majority; 1st substitute bill be substituted, do pass.
  13. First reading, referred to Health & Long Term Care.
  14. Prefiled for introduction.

SB 5020 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page